StitchTrade1

Leviathan238
Leviathan238 Nov 11, 15 8:47 AM

Just FYI, a company is not profitable if it's reporting a negative EPS. Revenues minus expenses = profit.

StitchTrade1
StitchTrade1 Nov 11, 15 10:28 AM

referring to gross profit: The company's gross profit for the quarter ended September 30, 2015 was $0.1 million compared to a gross loss of $0.1 million for the same period in 2014. The improvement of 217.1% was largely attributable to the increase in product revenues and a decrease of write-offs of inventory of MGuard™ Prime EPS

StitchTrade1
StitchTrade1 Nov 11, 15 10:29 AM

still had a net loss, so should have pointed that out.

Join now or log in to leave a comment

StitchTrade1

biggtyma
2biggtyma Oct 21, 15 4:50 PM

it could spike again because earnings winners can spike more than once or there could be a short squeeze. It has held its gains nicely so i dont see a panic tomorrow. Wait for price action if you want to short this pos but dont underestimate earnings winners and stupidity

Palmer
2Palmer Oct 21, 15 4:53 PM

I agree with TBEKG...you have to simply trade the stock, or any stock (trade not invest) per what the reaction is right now. What is it doing right now, not where HLX was when it was almost $50. IT would take A LOT to get this stock back to where it was. If you think it will, buy $500 worth and forget about it for a long time. Trade it now with 500 shares and make more in the next 10 minutes than you would in the next 10 months. It's all about the now...

StitchTrade1
1StitchTrade1 Oct 21, 15 5:14 PM

makes sense and thanks for the feedback. I think people will realize this picture is bad and dump the spike

Learnthings
Learnthings Oct 22, 15 12:52 AM

i agree with the above posts. the first thing that came to my mind was how Tim talks about the company not mattering...only what people think about the company. I apreciate your insights. I'm getting a lot of good info from following traders like you (high win %.) :]

Join now or log in to leave a comment

StitchTrade1

StitchTrade1
StitchTrade1 Sep 18, 15 8:33 AM

InspireMD continues to maintain a focus on its intellectual property portfolio, expanding coverage for its proprietary MicroNetTM technology, CGuardTM Embolic Prevention System for the treatment of carotid artery disease, and MGuardTM for coronary applications, in addition to several pending applications directed to its neurovascular and peripheral vascular platforms. The issuance of these two patents provides further support for these pending therapies and applications. To-date, the Company’s p

StitchTrade1
StitchTrade1 Sep 18, 15 8:34 AM

To-date, the Company’s patent rights in the United States include 4 issued patents and 10 pending applications. Foreign patent rights include 13 issued patents focused in Israel, Canada, and China, and 16 pending patent applications.

Join now or log in to leave a comment

List results per page:510152025
Page 1 of 4